Have you finished first line chemotherapy for s... - My Ovacome

My Ovacome

18,349 members20,425 posts

Have you finished first line chemotherapy for stage 3 or 4 ovarian, fallopian tube or primary peritoneal cancer in the last 2 to 12 months?

OvacomeSupport profile image
OvacomeSupportPartnerMy Ovacome Team
0 Replies

Good morning all

Have you finished first line (initial) chemotherapy for stage 3 or 4 ovarian, fallopian tube or primary peritoneal cancer in the last 2 to 12 months?

If so, you may be eligible to take part in an important new study looking at how care could be improved for people diagnosed, throughout the various stages of their treatment.

The study is non-interventional, meaning that you won’t be given treatment as part of the study. Instead, you’ll be asked to share your experiences through a survey.

All study participants will receive £50 on successful completion of the survey.

Ovacome is partnering with a panel of clinicians for this piece of work, which will submitted for publication in a peer-reviewed journal.

If you’d like to learn more about getting involved, please our website for more information ➡️ ovacome.org.uk/news/patron. Please call our support team on 0800 008 7054 or email support@ovacome.org.uk if you would like more information about taking part in this research.

Please don't hesitate to get in touch if you have any questions, or if there's anything we can do to support your participation.

Best wishes

Annie - Ovacome support

Written by
OvacomeSupport profile image
OvacomeSupport
Partner
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Have you finished first line chemotherapy for stage 3 or 4 ovarian, fallopian tube or primary peritoneal cancer in the last 2 to 12 months?

Good morning all Have you finished first line (initial) chemotherapy for stage 3 or 4 ovarian,...
OvacomeSupport profile image
Partner

Your help needed to promote My Ovacome

Hello All You may have seen my post about this before Christmas, apologies for the repetition but...
OvacomeSupport profile image
Partner

Leaving a legacy

Have you thought about supporting Ovacome by leaving a gift in your will? By making a will you...

NICE review olaparib and bevacizumab - your comments needed

Good morning everyone, NICE are undertaking a Cancer Drugs Fund guidance review of Olaparib in...
OvacomeSupport profile image
Partner

Niraparib - NICE appraisal

Dear All The National Institute for Health and Care Excellence (NICE) have contacted Ovacome...
OvacomeSupport profile image
Partner